Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

New therapies are being developed that target integrin pathways to treat various diseases.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.